SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,018,313 | -11.2% | 16,650 | -16.1% | 2.60% | -4.8% |
| Q2 2023 | $2,271,619 | -54.5% | 19,836 | -45.2% | 2.74% | -60.4% |
| Q1 2023 | $4,988,068 | -39.6% | 36,190 | -43.2% | 6.91% | -12.9% |
| Q4 2022 | $8,261,502 | +24.1% | 63,756 | +5.9% | 7.93% | +23.9% |
| Q3 2022 | $6,658,000 | +76.8% | 60,231 | +19.9% | 6.40% | +56.2% |
| Q2 2022 | $3,765,000 | -18.7% | 50,225 | -15.3% | 4.10% | +27.3% |
| Q1 2022 | $4,632,000 | -46.8% | 59,299 | -38.7% | 3.22% | -23.0% |
| Q4 2021 | $8,707,000 | +8.0% | 96,695 | +10.9% | 4.18% | +16.8% |
| Q3 2021 | $8,065,000 | +32.5% | 87,213 | +11.3% | 3.58% | +27.5% |
| Q2 2021 | $6,089,000 | +18.5% | 78,330 | +13.6% | 2.81% | -7.6% |
| Q1 2021 | $5,138,000 | +1.6% | 68,937 | +132.3% | 3.04% | -21.2% |
| Q4 2020 | $5,059,000 | – | 29,672 | – | 3.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |